AB Mayerson, RS Hundal, S Dufour, V Lebon, … - Diabetes, 2002 - Am Diabetes Assoc We examined the effect of three months of rosiglitazone treatment (4 mg bid) on
whole-body insulin sensitivity and in vivo peripheral adipocyte insulin
sensitivity as assessed by glycerol release in microdialysis from ... Cited by 417 - Related articles - BL Direct - All 4 versions
Y Miyazaki, L Glass, C Triplitt, M Matsuda, … - Diabetologia, 2001 - Springer The thiazolidinediones represent a new class of insu- lin sensitizing agents for
the treatment of Type II (non-insulin-dependent) diabetes mellitus. The origi-
nal drug in this class, troglitazone, has been shown to ameliorate insulin ... Cited by 204 - Related articles - BL Direct - All 5 versions
M Bajaj, S Suraamornkul, T Pratipanawatr, LJ … - Diabetes, 2003 - Am Diabetes Assoc The effect of pioglitazone on splanchnic glucose uptake (SGU), endogenous
glucose production (EGP), and hepatic fat content was studied in 14 type 2
diabetic patients (age 50 ± 2 years, BMI 29.4 ± 1.1 kg/m 2 , HbA 1c 7.8 ... Cited by 165 - Related articles - BL Direct - All 4 versions
- ►endojournals.org Y Miyazaki, A Mahankali, M Matsuda, S … - Journal of Clinical Endocrinology & Metabolism, 2002 - Endocrine Soc We examined the effect of pioglitazone on abdominal fat distribution to
elucidate the mechanisms via which pioglitazone improves insulin resistance in
patients with type 2 diabetes mellitus. Thirteen type 2 diabetic patients ... Cited by 333 - Related articles - BL Direct - All 8 versions
DG Carey, GJ Cowin, GJ Galloway, NP Jones, … - Obesity, 2002 - nature.com Results: There was a significant improvement in glycemic control (glycosylated
hemoglobin -0.7 0.7%, p 0.05) and an 86% increase in insulin sensitivity in the
RSG group (glucose-disposal rate change from baseline: 17.5 14.5 mol ... Cited by 128 - Related articles - All 3 versions
M Tiikkainen, AM Häkkinen, E Korsheninnikova … - Diabetes, 2004 - Am Diabetes Assoc Both rosiglitazone and metformin increase hepatic insulin sensitivity, but their
mechanism of action has not been compared in humans. The objective of this study
was to compare the effects of rosiglitazone and metformin treatment on ... Cited by 275 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org Y Miyazaki, A Mahankali, M Matsuda, L Glass, … - Diabetes Care, 2001 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A total of 23 diabetic patients (age 30–70
years, BMI < 36 kg/m 2 ) who were being treated with a stable dose of
sulfonylurea were randomly assigned to receive either placebo (n = 11) or ... Cited by 271 - Related articles - BL Direct - All 7 versions
- ►annals.org DG Maggs, TA Buchanan, CF Burant, G Cline, B … - Annals of internal medicine, 1998 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Troglitazone is a new insulin-sensitizing agent used to treat ... Cited by 267 - Related articles - BL Direct - All 6 versions
L Ryysy, AM Hakkinen, T Goto, S Vehkavaara, … - DIABETES-NEW YORK-, 2000 - Am Diabetes Assoc Page 1. DIABETES, VOL. 49, MAY 2000 749 Hepatic Fat Content and Insulin Action
on Free Fatty Acids and Glucose Metabolism Rather Than ... Cited by 209 - Related articles - BL Direct - All 7 versions
- ►endojournals.org HE Lebovitz, JF Dole, R Patwardhan, EB … - Journal of Clinical Endocrinology & Metabolism, 2001 - Endocrine Soc This study evaluated the efficacy and safety of rosiglitazone monotherapy in
patients with type 2 diabetes. After a 4-week placebo run-in period, 493
patients with type 2 diabetes were randomized to receive rosiglitazone [2 ... Cited by 414 - Related articles - BL Direct - All 5 versions
